Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, representing an internal update to the page metadata. No user-visible content changes are indicated.
    Difference
    0.0%
    Check dated 2026-05-15T05:39:45.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a backend/UI version change rather than any change to the displayed trial study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:46:41.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:13:11.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-04-02T14:49:28.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T22:37:42.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and v3.4.2 removed; this is a minor versioning update with no changes to study data or page behavior.
    Difference
    0.0%
    Check dated 2026-03-11T20:00:23.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.